BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%
- Manufacturer
- Sincerus Florida, LLC
- Effective date
- 2019-05-15
- Label type
- HUMAN PRESCRIPTION DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 20:28:46
Label at a glance#
ProductBRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%
Active ingredientBRIMONIDINE TARTRATE, METRONIDAZOLE, NIACINAMIDE, IVERMECTIN
Label structure4 sections
Label contents#
Full prescribing information#
Sincerus Florida, LLC. Adverse reactions
Active, inactive
NDC 72934- 1028-2 BRIMONIDINE TARTRATE USP 0.25% / IVERMECTIN USP 1% / METRONIDAZOLE USP 1% / NIACINAMIDE USP 4%
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| BRIMONIDINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230503 |
| IVERMECTIN Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| METRONIDAZOLE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 72934-1028-2 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-44d9-a910-e053-dadaa90a0b85 | BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72934-1028-2 | BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% | 30 g in 1 BOTTLE, PUMP | GEL | 30 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72934-1028 | BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4% GEL [SINCERUS FLORIDA, LLC] | 1 | Legacy NDC, 1 package rows | 20190516_88f00580-a0c9-168f-e053-2a95a90a6e4b.zip |
Products#
Every source-derived product name is available through these pages.
- BRIMONIDINE TARTRATE 0.25% / IVERMECTIN 1% / METRONIDAZOLE 1% / NIACINAMIDE 4%
- BRIMONIDINE TARTRATE
- BRIMONIDINE
- METRONIDAZOLE
- NIACINAMIDE
- IVERMECTIN
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 72934-1028 | 72934-1028-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BRIMONIDINE TARTRATE | 4S9CL2DY2H | ACTIB |
| METRONIDAZOLE | 140QMO216E | ACTIB |
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| IVERMECTIN | 8883YP2R6D | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 88f00580-a0ca-168f-e053-2a95a90a6e4b | 88f00580-a0c9-168f-e053-2a95a90a6e4b | 2019-05-15 | Adverse reactions | 88f00580-a0ca-168f-e053-2a95a90a6e4b 88f00580-a0c9-168f-e053-2a95a90a6e4b |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


